Pulmonary Sarcoidosis Associated with Etanercept Therapy
- 1 October 2007
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 27 (10) , 1446-1448
Abstract
We present a case of probable pulmonary sarcoidosis associated with the use of etanercept for psoriatic arthritis. Other cases of etanercept‐induced granulomas and skin sarcoidosis were recently published in the medical literature, but we found only one case that involved lung sarcoidosis during etanercept therapy. We describe a 40‐year‐old man who was receiving etanercept for severe psoriatic arthritis and was admitted to the hospital with dyspnea and subfebrile illness several months after the start of treatment. His diagnosis was consistent exclusively with sarcoidosis. The patient's symptoms improved when etanercept was discontinued, but they did not resolve completely. Treatment with prednisone 40 mg led to complete improvement of his pulmonary disease. Etanercept therapy can induce or exacerbate sarcoidosis. The disease disappears when etanercept is discontinued, although treatment with corticosteroids is sometimes required, as in our patient. Use of the Naranjo adverse drug reaction probability scale revealed a probable likelihood (score of 6) that the adverse reaction was related to etanercept. The association of etanercept with sarcoidosis is still a rare finding. This case highlights the importance of monitoring and possibly discontinuing the drug when sarcoidosis is suspected. Patients should be monitored during and after etanercept therapy for manifestations suggesting sarcoidosis, and we recommend patients receive baseline chest radiography at the start of therapy with follow‐up of respiratory symptoms.Keywords
This publication has 17 references indexed in Scilit:
- Development of sarcoidosis during etanercept therapyArthritis Care & Research, 2006
- RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLIXIMAB IN PATIENTS WITH CHRONIC PULMONARY SARCOIDOSISChest, 2005
- Granulomatous lung disease occurring during etanercept treatmentArthritis & Rheumatism, 2005
- Chronic sarcoid arthritis treated with intraarticular etanerceptArthritis & Rheumatism, 2005
- Treatment of Sarcoidosis With InfliximabChest, 2005
- The utility of tumour necrosis factor blockade in orphan diseasesAnnals of the Rheumatic Diseases, 2004
- Systemic sarcoidosis and cutaneous lymphoma: is the association fortuitous?British Journal of Dermatology, 1999
- ETIOLOGY OF SARCOIDOSISClinics in Chest Medicine, 1997
- Pulmonary SarcoidosisNew England Journal of Medicine, 1981
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981